These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 30260647)
1. Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells. Melamed JR; Ioele SA; Hannum AJ; Ullman VM; Day ES Mol Pharm; 2018 Nov; 15(11):5135-5145. PubMed ID: 30260647 [TBL] [Abstract][Full Text] [Related]
2. Essential role of Gli proteins in glioblastoma multiforme. Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423 [TBL] [Abstract][Full Text] [Related]
3. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway. Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060 [TBL] [Abstract][Full Text] [Related]
4. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181 [TBL] [Abstract][Full Text] [Related]
5. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway. Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920 [TBL] [Abstract][Full Text] [Related]
6. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008 [TBL] [Abstract][Full Text] [Related]
9. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism. Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182 [TBL] [Abstract][Full Text] [Related]
11. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies. Fadera S; Chen PY; Liu HL; Lee IC ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925 [TBL] [Abstract][Full Text] [Related]
12. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
13. Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells. Noh H; Zhao Q; Yan J; Kong LY; Gabrusiewicz K; Hong S; Xia X; Heimberger AB; Li S Cancer Lett; 2018 Oct; 433():176-185. PubMed ID: 29991446 [TBL] [Abstract][Full Text] [Related]
14. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863 [TBL] [Abstract][Full Text] [Related]
15. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo. Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379 [TBL] [Abstract][Full Text] [Related]
16. Role of Sonic hedgehog signaling in cell cycle, oxidative stress, and autophagy of temozolomide resistant glioblastoma. Honorato JR; Hauser-Davis RA; Saggioro EM; Correia FV; Sales-Junior SF; Soares LOS; Lima LDR; Moura-Neto V; Lopes GPF; Spohr TCLS J Cell Physiol; 2020 Apr; 235(4):3798-3814. PubMed ID: 31613002 [TBL] [Abstract][Full Text] [Related]
17. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway. Yang W; Liu Y; Gao R; Yu H; Sun T Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038 [TBL] [Abstract][Full Text] [Related]
18. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456 [TBL] [Abstract][Full Text] [Related]